Bloomberg Anywhere Remote Login Bloomberg Terminal Demo Request


Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.


Financial Products

Enterprise Products


Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000


Industry Products

Media Services

Follow Us

Last --
Change Today 0.00 / 0.00%
Volume 0.0
3401 On Other Exchanges
3401 is not on other exchanges.
All times are local (Market data is delayed by at least 15 minutes).

teijin ltd (3401) Snapshot

Previous Close
Day High
Day Low
52 Week High
-- - --
52 Week Low
-- - --
Market Cap
Average Volume 10 Days
Shares Outstanding
Dividend Yield
Current Stock Chart for TEIJIN LTD (3401)

Related News

No related news articles were found.

teijin ltd (3401) Related Businessweek News

No Related Businessweek News Found

teijin ltd (3401) Details

Teijin Limited provides solutions to transportation, information and electronics, safety and protection, environment and energy, and healthcare areas worldwide. The company’s Advanced Fibers and Composites segment offers para-aramid, meta-aramid, polyester, and polyethylene naphthalate (PEN) fibers; synthetic leather; carbon fibers and intermediate materials; carbon fiber reinforced composites; and flame-resistant fibers. Its Electronics Materials and Performance Polymer Products segment provides polycarbonate (PC) resins, PC/ABS and PC/AS polymer alloys, PEN resins, polyethylene terephthalate (PET) resins, polybutylene naphthalete resins, bromine series flame retardants, PET and PEN films, processed films, monomers, and polymers. The company’s Healthcare segment offers Bonalon and Onealfa for the treatment of osteoporosis; Synvisc to treat knee osteoarthritis pain; sonic accelerated fracture healing systems; Mucosolvan, an expectorant; and Alvesco, an inhaled corticosteroid agent for asthma. This segment also provides oxygen concentrators for home oxygen therapy; continuous positive airway pressure units; NIP NASAL, a non-invasive positive pressure ventilator; AutoSet CS, an adaptive servo-ventilator; Feburic to treat hyperuricemia and gout; Tricor for hyperlipidemia; and Venilon for Intravenous immunoglobulin preparation. Its Trading and Retail segment sells and trades fibrous raw material, apparel, industrial materials, and performance polymer products. The company also offers IT services in the healthcare field, Web-based enterprise resource planning, and digital content management services; content distribution services for mobile phones and smartphones, and e-commerce services; and polyester raw materials and polymerization services. Teijin Limited was founded in 1918 and is headquartered in Osaka, Japan.

15,780 Employees
Last Reported Date: 06/24/15
Founded in 1918

teijin ltd (3401) Top Compensated Officers

No compensation data is available at this time for the top officers at this company.

Executives, Board Directors

teijin ltd (3401) Key Developments

Teijin Ltd. Announces Earnings Results for the First Half Ended September 30, 2015; Revises Earnings Guidance for the Fiscal Year Ending March 31, 2016

Teijin Ltd. announced consolidated earnings results for the first half ended September 30, 2015. For the period, the company reported net sales of JPY 392,057 million against JPY 377,399 million a year ago. Operating income was JPY 35,339 million against JPY 12,127 million for the same period in the last year. Ordinary income was JPY 35,846 million against JPY 14,042 million for the same period in the last year. Net income was JPY 24,464 million or JPY 22.58 per share against net loss of JPY 22,346 million for the same period in the last year. Loss before income taxes was JPY 32,995 million against loss before income taxes of JPY 27,978 million a year ago. Net cash and cash equivalents provided by operating activities was JPY 26,349 million against JPY 22,836 million a year ago. Purchase of property, plant and equipment was JPY 14,663 million against JPY 15,107 million a year ago. Purchase of intangible assets was JPY 1,233 million against JPY 1,113 million a year ago. EBITDA was JPY 54.4 billion against JPY 34.4 billion a year ago. Interest-bearing debt was JPY 283.6 billion as on September 30, 2015 against JPY 308.2 billion as on March 31, 2015. For the fiscal year ending March 31, 2016, the company expects net sales of JPY 790,000 million, up 0.5% compared to previous guidance, operating income of JPY 58,000 million up 48.4% compared to previous guidance, ordinary income of JPY 58,000 million up 36.9% compared to previous guidance, and net income of JPY 34,000 million or JPY 34.59 per share. Operating margin expected to be 7.3% against previous guidance of 6.5%. Capex expected to be JPY 34.0 billion against previous guidance of JPY 30.0 billion. Depreciation and amortization expected to be JPY 40.0 billion against previous guidance of JPY 40.0 billion. ROA expected to be 6.9%. ROE expected to be 11.4%. EBITDA expected to be JPY 98.0 billion.

Teijin Ltd. Revises Year-End Dividend for the Year Ending March 31, 2016

Teijin Ltd. revised its year-end dividend forecast to ¥4.00 per share, from ¥3.00 per share previously forecasted for the year ending March 31, 2016. As a result, the full-term dividend forecast has been revised from ¥6.00 per share to ¥7.00 per share.

Teijin Ltd., Q2 2016 Earnings Call, Nov 02, 2015

Teijin Ltd., Q2 2016 Earnings Call, Nov 02, 2015


Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
3401:JP ¥444.00 JPY -4.00

3401 Competitors

Market data is delayed at least 15 minutes.

Company Last Change
Celanese Corp $70.59 USD -0.16
LANXESS AG €47.20 EUR -1.13
Mitsui Chemicals Inc ¥532.00 JPY +5.00
Trinseo SA $29.25 USD +0.69
View Industry Companies

Industry Analysis


Industry Average

Valuation 3401 Industry Range
Price/Earnings 11.6x
Price/Sales 0.5x
Price/Book 1.4x
Price/Cash Flow 9.5x
TEV/Sales 0.1x

Sponsored Financial Commentaries

Sponsored Links

Request Profile Update

Only a company representative may request an update for the company profile. Documentation will be required.

To contact TEIJIN LTD, please visit Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at